Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



Icahn Targets Mylan

Where there is trouble, chances are good billionaire Carl Icahn won't be far from view. The corporate raider has a penchant for taking over companies, replacing bungling executives, and boosting value. His arrival yesterday at the doorstep of troubled generic-drug maker Mylan Laboratories (NYSE: MYL  ) could be bad news for Mylan's management but good news for shareholders.

Mylan has been stumbling lately. Things went from bad to worse in July with Mylan's decision to acquire King Pharmaceuticals (NYSE: KG  ) . The deal is a stinker. Mylan is paying $4 billion for a poorly performing company that's under investigation for its trading and financial reporting practices. Even worse, King may not deliver a big punch in the branded cardiac drug business that Mylan hopes to enter. On announcing the deal, Mylan stock went into a tailspin and has been hovering near its 52-week low.

Yesterday, Icahn got the green light from regulators to purchase up to 11.9% of Mylan shares. His move need not be the first stage of a hostile takeover, since he has not officially stated his motives. Mylan stock shot up 10% yesterday, so he could conceivably walk away with a tidy profit.

Negotiations are more likely. Expect talks when Icahn eventually meets up with Mylan's top brass, not a punch-up. Mylan CEO Robert Coury will try to calm down shareholders and prevent them from joining forces with Icahn to win a proxy fight.

Even so, Mylan executives should be scared. They openly remain committed to an acquisition that, judging by the share price, a lot of shareholders don't like. This could be the dawn of a management shake-up.

More Mylan:

Fool contributorBen McClure hails from the Great White North. He doesn't own shares of either company mentioned here.

Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 501138, ~/Articles/ArticleHandler.aspx, 10/27/2016 8:36:09 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,169.68 -29.65 -0.16%
S&P 500 2,133.04 -6.39 -0.30%
NASD 5,215.97 -34.29 -0.65%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

12/31/1969 7:00 PM
KG.DL2 $0.00 Down +0.00 +0.00%
King Pharmaceutica… CAPS Rating: **
MYL $38.02 Down -0.06 -0.16%
Mylan CAPS Rating: ***